SCHEMBL1084667

SCHEMBL1084667

Cc1ccc2c(N3CCCCCC3c3ccccc3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.50
KDM4E B2RXH2 4/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
SMAD3 P84022 1/20 0.50
LMNA P02545 4/20 0.46
HIF1A Q16665 3/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
CHEK2 O96017 2/20 0.45
HTT P42858 1/20 0.44
ALDH1A1 P00352 5/20 0.43
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
USP2 O75604 2/20 0.43
MAPK1 P28482 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084457 0.96 SMAD3 (0.49) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084543 0.90 SMAD3 (0.44) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084105 0.89 SMAD3 (0.43) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084056 0.89 SMAD3 (0.43) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084847 0.87 SMAD3 (0.42) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084494 0.87 SMAD3 (0.42) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084468 0.87 KMT2A (0.46) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1083922 0.87 GPR39 (0.42) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084507 0.86 MAPT (0.46) MAPTKDM4EL3MBTL1SMAD3LMNA
SCHEMBL1084121 0.86 HIF1A (0.45) MAPTKDM4EL3MBTL1SMAD3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed